Clinical Study of Flumazenil Antagonizing Remimazolam on Nausea and Vomiting After Gynecologic Day Surgery

References

• Yu D, Liu X. Visualization and analysis of our ambulatory surgery policy documents. China Health Qual Manage. 2022;29(10):31–34.
   Google Scholar
• White PF, Sacan O, Nuangchamnong N, et al. The relationship between patient risk factors and early versus late postoperative emetic symptoms. Anesth Analg. 2008;107(2):459–463. doi:10.1213/ane.0b013e31817aa6e4
   PubMed Web of Science ®Google Scholar
• Schüttler J, Eisenried A, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132(4):636–651. doi:10.1097/ALN.0000000000003103
   PubMed Web of Science ®Google Scholar
• Worthington MT, Antonik LJ, Goldwater DR, et al. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg. 2013;117(5):1093–1100. doi:10.1213/ANE.0b013e3182a705ae
   PubMed Web of Science ®Google Scholar
• Su M, Shengmei Z, et al. Expert consensus on the management of anesthesia for hysteroscopic diagnosis and treatment. 2020. Available from: https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=LCMZ202011023&dbname=CJFDLAST2020. Accessed 26 February 2024.
   Google Scholar
• Murphy MJ, Hooper VD, Sullivan E, et al. Identification of risk factors for postoperative nausea and vomiting in the perianesthesia adult patient. J Perianesth Nurs. 2006;21(6):377–384. doi:10.1016/j.jopan.2006.09.002
   PubMedGoogle Scholar
• Apfel CC, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91(3):693–700. doi:10.1097/00000542-199909000-00022
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21(1):55–89. doi:10.1210/edrv.21.1.0389
   PubMed Web of Science ®Google Scholar
• Antonik LJ, Goldwater DR, Kilpatrick GJ, et al. A placebo- and midazolam-controlled Phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115(2):274–283. doi:10.1213/ANE.0b013e31823f0c28
   PubMed Web of Science ®Google Scholar
• Luo W, Sun M, Wan J, et al. Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial. BMC Anesthesiol. 2023;23(1):182. doi:10.1186/s12871-023-02092-2
   PubMedGoogle Scholar
• Ahn EJ, Kang H, Choi GJ, et al. The effectiveness of midazolam for preventing postoperative nausea and vomiting: a systematic review and meta-analysis. Anesth Analg. 2016;122(3):664–676. doi:10.1213/ANE.0000000000001062
   PubMed Web of Science ®Google Scholar
• Lee Y, Wang JJ, Yang YL, et al. Midazolam vs ondansetron for preventing postoperative nausea and vomiting: a randomised controlled trial. Anaesthesia. 2007;62(1):18–22. doi:10.1111/j.1365-2044.2006.04895.x
   PubMed Web of Science ®Google Scholar
• Bauer KP, Dom PM, Ramirez AM, et al. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth. 2004;16(3):177–183. doi:10.1016/j.jclinane.2003.07.003
   PubMed Web of Science ®Google Scholar
• Penninga EI, Graudal N, Ladekarl MB, et al. Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication--a systematic review with meta-analyses of randomised trials. Basic Clin Pharmacol Toxicol. 2016;118(1):37–44. doi:10.1111/bcpt.12434
   PubMed Web of Science ®Google Scholar
• Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth. 2002;88(5):659–668. doi:10.1093/bja/88.5.659
   PubMed Web of Science ®Google Scholar
• Myles PS, Leslie K, Chan MT, et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology. 2007;107(2):221–231. doi:10.1097/01.anes.0000270723.30772.da
   PubMed Web of Science ®Google Scholar
• Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113. doi:10.1213/ANE.0000000000000002
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Kawashima S, Makino H, et al. Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study. Korean J Anesthesiol. 2023;76(2):143–151. doi:10.4097/kja.22441
   PubMed Web of Science ®Google Scholar
• Peprah K, Mccormack S. CADTH rapid response reports. In: Ondansetron in Patients Requiring Anti-Emetics: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health Copyright © 2020 Canadian Agency for Drugs and Technologies in Health; 2020.
   Google Scholar
• Xiao H, Liu M, Man Y, et al. Effect of low-dose propofol combined with dexamethasone on the prevention of postoperative nausea and vomiting in gynaecological day surgery under remimazolam-based general anesthesia. Medicine. 2023;102(10):e33249. doi:10.1097/MD.0000000000033249
   PubMed Web of Science ®Google Scholar
• Yi F, Xiao H, Zhu T, et al. Prevention of postoperative nausea and vomiting after gynaecological day surgery under remimazolam general anesthesia: a randomized double-blind controlled study. BMC Anesthesiol. 2022;22(1):292. doi:10.1186/s12871-022-01835-x
   PubMed Web of Science ®Google Scholar
• Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350(24):2441–2451. doi:10.1056/NEJMoa032196
   PubMed Web of Science ®Google Scholar
• Lee SP, Sung IK, Kim JH, et al. Efficacy and safety of flumazenil injection for the reversal of midazolam sedation after elective outpatient endoscopy. J Dig Dis. 2018;19(2):93–101. doi:10.1111/1751-2980.12579
   PubMed Web of Science ®Google Scholar
• Jones RD, Lawson AD, Andrew LJ, et al. Antagonism of the hypnotic effect of midazolam in children: a randomized, double-blind study of placebo and flumazenil administered after midazolam-induced anaesthesia. Br J Anaesth. 1991;66(6):660–666. doi:10.1093/bja/66.6.660
   PubMed Web of Science ®Google Scholar
• Ngo AS, Anthony CR, Samuel M, et al. Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department? Resuscitation. 2007;74(1):27–37. doi:10.1016/j.resuscitation.2006.11.010
   PubMed Web of Science ®Google Scholar
• Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med. 2022;17(1):1–11. doi:10.17085/apm.21115
   Google Scholar